DNA methylation markers in esophageal cancer: an emerging tool for cancer surveillance and treatment.

Wang, He; DeFina, Samuel M; Bajpai, Manisha; Yan, Qin; Yang, Lei; Zhou, Zhongren

Wang, He; DeFina, Samuel M; Bajpai, Manisha; Yan, Qin; Yang, Lei; Zhou, Zhongren.

Affiliation

Wang H; Department of Pathology, Yale School of Medicine, Yale University New Haven, Connecticut, United States.
DeFina SM; Department of Pathology, Yale School of Medicine, Yale University New Haven, Connecticut, United States.
Bajpai M; Department of Medicine-Gastroenterology and Hepatology, Rutgers-Robert Wood Johnson Medical School, Rutgers The State University of New Jersey New Brunswick, NJ, United States.
Yan Q; Department of Pathology, Yale School of Medicine, Yale University New Haven, Connecticut, United States.
Yang L; Department of Pathology, Yale School of Medicine, Yale University New Haven, Connecticut, United States.
Zhou Z; Department of Pathology & Laboratory Medicine, Rutgers-Robert Wood Johnson Medical School, Rutgers The State University of New Jersey New Brunswick, NJ, United States.

Am J Cancer Res ; 11(11): 5644-5658, 2021.

Article de En | MEDLINE | ID: mdl-34873485

Mots clés

DNA methylation; DNMT inhibitors; Esophageal carcinoma; cancer precursor lesion

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Screening_studies Langue: En Journal: Am J Cancer Res Année: 2021 Type de document: Article Pays d'affiliation: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google